Navidea Biopharma (NAVB) Reports Q4 Loss of $0.03

Navidea Biopharma (NYSE: NAVB) reported Q4 EPS of ($0.03), versus ($0.02) reported last year. Revenue for the quarter came in at $395 thousand, versus $1 million reported last year.

For earnings history and earnings-related data on Navidea Biopharma (NAVB) click here.

You May Also Be Interested In

• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh
• AeroVironment (AVAV) Tops Q1 EPS by 29c, Offers Guidance
• Core & Main, Inc (CNM) Tops Q3 EPS by 2c ; Offers Guidance